Management of Neovaginal Secretions After Salvage Gender Affirming Right-Colon Vaginoplasty Using Glycopyrrolate

Transgend Health. 2023 Oct 4;8(5):477-480. doi: 10.1089/trgh.2021.0158. eCollection 2023 Oct.

Abstract

Purpose: We report a novel case of a transgender woman who experienced excess mucosal secretion leading to symptomatic skin irritation after her colonic vaginoplasty successfully treated with glycopyrrolate.

Methods: This is a case report of a 47-year-old transgender woman with symptomatic excess mucosal secretion and skin irritation from colonic vaginoplasty, and we describe her treatment course and responses. Patient consent was obtained for publication.

Results: The patient's chronic neovaginal discharge improved with glycopyrrolate.

Conclusions: Anticholinergic drugs may be helpful in treating patients who experience chronic neovaginal discharge following colonic vaginoplasty.

Keywords: anticholinergics; colonic vaginoplasty; neovagina; neovaginal discharge; transgender; vaginoplasty.